Andrew M Naidech
Overview
Explore the profile of Andrew M Naidech including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
3335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Iorga M, Badhe S, Zhang J, Cantrell D, Tanhehco E, et al.
Radiol Artif Intell
. 2024 Aug;
6(6):e230296.
PMID: 39194400
Purpose To develop a highly generalizable weakly supervised model to automatically detect and localize image-level intracranial hemorrhage (ICH) by using study-level labels. Materials and Methods In this retrospective study, the...
2.
Murphy J, Silva Pinheiro do Nascimento J, Houskamp E, Wang H, Hutch M, Liu Y, et al.
Neurocrit Care
. 2024 Aug;
42(1):39-47.
PMID: 39107659
Background: The objective of this study was to define clinically meaningful phenotypes of intracerebral hemorrhage (ICH) using machine learning. Methods: We used patient data from two US medical centers and...
3.
Houskamp E, Liu Y, Silva Pinheiro do Nascimento J, Jahromi B, Lindholm P, Kwaan H, et al.
Ann Clin Transl Neurol
. 2024 Apr;
11(6):1535-1540.
PMID: 38654459
Objective: Hematoma expansion (HE) predicts disability and death after acute intracerebral hemorrhage (ICH). Aspirin and anticoagulants have been associated with HE. We tested the hypothesis that P2Y12 inhibitors predict subsequent...
4.
Alwakeal A, Maas M, Naidech A, Jahromi B, Potts M
Crit Care Med
. 2024 Feb;
52(5):811-820.
PMID: 38353592
Objectives: Four-factor prothrombin complex concentrate (4-PCC) is recommended for rapid reversal of vitamin K antagonists (VKAs) such as warfarin, yet optimal dosing remains uncertain. Data Sources: A systematic review was...
5.
Naidech A, Wang H, Hutch M, Murphy J, Paparello J, Bath P, et al.
BMJ Neurol Open
. 2023 Aug;
5(2):e000458.
PMID: 37529670
Background: Acute blood pressure (BP) reduction is standard of care after acute intracerebral haemorrhage (ICH). More acute BP reduction is associated with acute kidney injury (AKI). It is not known...
6.
Bilaver L, Wang H, Naidech A, Luo Y, Das R, Sehgal S, et al.
J Allergy Clin Immunol Pract
. 2023 Apr;
11(7):2242-2244.e2.
PMID: 37094730
No abstract available.
7.
Liu Y, Luo Y, Naidech A
Neurotherapeutics
. 2023 Mar;
20(3):744-757.
PMID: 36899137
The last decade has seen significant advances in the accumulation of medical data, the computational techniques to analyze that data, and corresponding improvements in management. Interventions such as thrombolytics and...
8.
Arnold L, Carroll C, Eberlein B, Naidech A, Colfer K, Ramsey K, et al.
Comput Inform Nurs
. 2023 Feb;
41(9):725-729.
PMID: 36728039
During the first COVID surge, multiple changes in nurse staffing and workflows were made to support care delivery in a resource-constrained environment. We hypothesized that there was a higher rate...
9.
Broderick J, Aziz Y, Adeoye O, Grotta J, Naidech A, Barreto A, et al.
Stroke
. 2022 Dec;
54(2):632-638.
PMID: 36533521
Randomized clinical trials of acute stroke have led to major advances in acute stroke therapy over the past decade. Despite these successes, recruitment in acute trials is often difficult. We...
10.
Maas M, Naidech A, Batra A, Chou S, Bleck T
Neurocrit Care
. 2022 Jun;
37(2):597-598.
PMID: 35761124
No abstract available.